Hypertension affects roughly one-third of adults in the United Arab Emirates (UAE), while diabetes impacts approximately one in four UAE nationals. Biomerica, Inc., a global provider of advanced diagnostic solutions, announced that the UAE Ministry of Health and Prevention has approved its Fortel® Kidney Test for home use. This approval marks a significant step in expanding access to accurate and easy-to-use diagnostic tools that support the early identification of kidney damage in high-risk populations.
The 10-minute home test is designed to detect early signs of kidney damage in diabetic and hypertensive patients. With hypertension affecting one-third of adults in the UAE and diabetes impacting a significant portion of UAE nationals, the approval of this test is crucial for early intervention and management of kidney health. The Fortel® Kidney Test provides a convenient way for individuals to monitor their kidney health from the comfort of their homes, allowing for timely detection of any potential issues.
Biomerica’s Fortel® Kidney Test approval by the UAE Ministry of Health and Prevention comes as a boon for those at risk of kidney damage due to diabetes and hypertension. By empowering individuals with an easy-to-use and accurate test, the Ministry aims to improve the early diagnosis and management of kidney-related issues, ultimately enhancing the overall health outcomes of high-risk populations in the UAE.
The United Arab Emirates’ approval of Biomerica’s Fortel® Kidney Test underscores the country’s commitment to advancing healthcare solutions for its populace. With the prevalence of hypertension and diabetes in the UAE, the availability of a reliable home test for early detection of kidney damage is a significant development in promoting proactive healthcare practices among the population. By granting approval for the Fortel® Kidney Test, the Ministry of Health and Prevention reaffirms its dedication to enhancing healthcare accessibility and outcomes in the UAE.
Deixe um comentário